Endometriosis: benign, malignant, or something in between?
editorial
OA: gold
CC0
⤵ 20 in-corpus citations
AI-generated summary
This paper explores the controversial classification of endometriosis, considering its benign, malignant, and intermediate characteristics within the spectrum of gynecological conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- Activation of mutated K‐ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis via openalex
- Cancer-Associated Mutations in Endometriosis without Cancer via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- W1970527559 via openalex
- W2130344626 via openalex
- W2305551225 via openalex
- W2048069897 via openalex
Cited by (23)
- Somatic Cancer Driver Mutation Analysis in Endometriosis with Tumor-like Presentations: A Case Series Study 2026
- Endometriosis: A Cancer-Like Phenomenon 2026
- Enacting gendered pathologies: Diffraction in medical practices of treating endometriosis and infertility 2026
- Living with acuteness in chronic illness: The temporal underpinnings of endometriosis 2025
- The effectiveness of surgical and conservative treatment of patients with endometriosis of the uterine scar after cesarean section 2024
- Endometriosis: Cell Death and Cell Signaling Machinery 2023
- The Comparative Invasiveness of Endometriotic Cell Lines to Breast and Endometrial Cancer Cell Lines 2023
- Clinical and anamnestic features of patients with endometriosis of an incompetent uterine scar after cesarian section 2022
- Combination of Ferulic Acid, Ligustrazine and Tetrahydropalmatine attenuates Epithelial-mesenchymal Transformation <i>via</i> Wnt/β-catenin Pathway in Endometriosis 2021
- Combination of ferulic acid, ligustrazine and tetrahydropalmatine inhibits invasion and metastasis through MMP/TIMP signaling in endometriosis 2021
- How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development 2021
- Evaluation of PTEN and Ki67 Expression in Typical and Atypical Endometriosis and Endometriosis Associated Ovarian Cancer 2020
- Inhibition of Jiawei Foshou San on invasion and metastasis through MMP/TIMP signaling in endometriosis 2020
- Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review 2020
- Association between endometriosis and gynecological cancers: a critical review of the literature 2020
- An Integrated Genomic Approach Identifies HOXC8 as an Upstream Regulator in Ovarian Endometrioma 2020
- The ultrasound of subcutaneous extrapelvic endometriosis 2020
- A mouse model of endometriosis mimicking the natural spread of invasive endometrium 2019
- The Origin and Pathogenesis of Endometriosis 2019
- Novel CTCF mutations in Chinese patients with ovarian endometriosis 2018
- Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
- The Endometriotic Tumor Microenvironment in Ovarian Cancer 2018
- Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology 2018
Source provenance
- europepmc
- last seen: 2026-09-13T09:25:22.628771+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:07.505861+00:00
License: CC0
· commercial use OK